Mortgage Blog Menlo Park’s ReCode Therapeutics raises $120M to build new vehicles for mRNA drugs, other therapies firststargroup June 30, 2022 The new funding is an extension of an $80 million Series B round disclosed in October.
The new funding is an extension of an $80 million Series B round disclosed in October.
